FIRE and ICE Trial (2014) A Controlled, Prospective, Non-Inferiority, Parallel-Group, Randomized, Interventional, Open, Blinded Outcome Assessment, Multi-Center Trial, Comparing Efficacy and Safety of Isolation of the Pulmonary Veins with a Cryoballoon Catheter versus a Radiofrequency Ablation with a ThermoCool Catheter in Patients with Paroxysmal Atrial Fibrillation. ClinicalTrials.gov Identifier NCT01490814.

has been cited by the following article:

• TITLE: Design and Baseline Patient Characteristics of the Prospective, Observational, Multicenter and Multinational Cohort Study Comparing Radiofrequency with Cryoablation for Pulmonary Vein Isolation in Patients with Atrial Fibrillation—The Freeze Cohort Study

  AUTHORS: Ellen Hoffmann, Uwe Dorwarth, Karl Heinz Kuck, Jürgen Vogt, Malte Kuniss, Steffen Schneider, Jürgen Tebbenjohanns, Kyong Ryul Julian Chun, Dietrich Andresen, Stefan Spitzer, Thorsten Lewalter, Stephan Willems, Johannes Brachmann, Christoph Stellbrink, Bernhard Rauch, Jochen Senges

  KEYWORDS: Atrial Fibrillation, Catheter Ablation, Cryoballoon Ablation, Radiofrequency Ablation, Registry

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.5 No.19, October 9, 2014

  ABSTRACT: Aims: The FREEZE-cohort study (NCT 01360008) is a prospective observational, multicenter and multinational study to evaluate safety and effectiveness of cryoballoon ablation for pulmonary vein isolation as compared to radiofrequency ablation in patients with paroxysmal or persistent atrial fibrillation (lasting